Skip to main content

MoneyWorks4Me

Lupin submits copy of additional clarification

30 Mar 2016 Evaluate

With reference to the news flashed on CNBC TV 18 ‘Mandideep unit inspected by US FDA from 8-19 Feb 2016. US FDA observations at Mandideep unit are serious in nature and the unit gets 483 letter’, Lupin has submitted a copy of additional Clarification.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..